Plerixafor and granulocyte-colony-stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non−Hodgkin's lymphoma: a randomized Phase 3 study

Author:

Zhu Jun1,Huang Huiqiang2,Chen Huan3,Zhang Xi4,Li Zengjun5,Wu Depei6,Zhou Daobin7,Song Yongping8,Hu Yu9,Liang Yingmin10,Ren Hanyun11,Huang He12,Li Nainong13,Chen Hu14,Hu Jiong15,Li Jianyong16,Meng Robin17,Wu Junlong18,Yu Dong19,Huang Xiaojun3

Affiliation:

1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education); Lymphoma Unit, Peking University Cancer Hospital and Institute; Beijing China

2. Department of Medical Oncology; Sun Yat-sen University Cancer Center; Guangzhou China

3. Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation; Peking University People's Hospital, Peking University Institute of Hematology; Beijing China

4. Department of Hematology; Xinqiao Hospital, Third Military Medical University; Chongqing China

5. Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; Tianjin China

6. Department of Hematology, First Affiliated Hospital of Soochow University; Suzhou China

7. Department of Hematology; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; Beijing China

8. Department of Hematology, Affiliated Tumor Hospital of Zhengzhou University; Zhengzhou; China

9. Department of Hematology; Union Hospital, Tongji Medical College of Huazhong University of Science and Technology; Wuhan China

10. Department of Hematology; Tangdu Hospital, Fourth Military Medical University; Xi'an China

11. Department of Hematology; Peking University First Hospital; Beijing China

12. First Affiliated Hospital of the Medical School of Zhejiang University; Bone Marrow Transplantation Center; Hangzhou China

13. Department of Hematology; Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital; Fuzhou China

14. Institute of Hematology, 307th Hospital of the Chinese People's Liberation Army; Beijing China

15. Department of Hematology; Ruijin Hospital Affiliated with the Shanghai Jiao Tong University School of Medicine; Shanghai China

16. Department of Hematology; First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital; Nanjing China

17. Sanofi Research and Development; Shanghai China

18. Sanofi Research and Development; Beijing China

19. Sanofi Medical; Shanghai China

Funder

Sanofi

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3